adm
.00
▁Increases
▁heterozygous
100
▁(0.9
MW
▁tubercle
▁weighing
infection
2]
ucl
▁63
mega
▁Hear
▁chewing
▁surgical
▁-10
▁41%
cellular
▁deficiency
▁scanning
▁hypot
▁commerc
▁Diagnostic
.3
ruc
osid
roxy
▁methodology
adren
▁pathologic
▁71%
omial
▁supra
▁fluids
▁anticholinergic
▁histological
▁Physicians
azin
uresis
▁quinolones
ucose
▁221
▁HSV
▁cytochrome
stro
oselective
▁preven
tained
▁condensed
▁compressive
▁5
▁IgA
▁uncommon
0.3
▁examinations
▁percutaneous
acetic
▁(1.9
▁HBs
pH
▁Optimal
▁clu
▁Haemophilus
erence
monary
▁paired
enicillin
▁aspec
▁125
▁resolving
treated
cribed
▁derm
icine
▁appra
▁(3.8
▁enroll
▁cytology
▁(2.5
dial
▁ovulation
35
▁RA
smokers
▁provid
erican
anding
▁favored
▁shorten
ostomy
▁aerosolized
▁swit
▁0.76
▁smear
▁arrhythmias
idase
vul
▁syncope
▁95%
00-
olones
▁intraven
▁70.
▁24%
▁bacteriuria
sively
▁splen
ivary
▁discontinuation
▁deem
▁supr
120
/4
OA
▁0.2%
ducing
keletal
onegative
▁0.0
▁electroly
▁suggestive
▁275
▁89
▁diverged
▁cylinder
▁exten
plen
onephritis
cancer
▁challen
▁influenz
consuming
▁chor
▁73
▁unexplained
▁39
▁lowers
27
▁focal
ulatory
▁adul
ophageal
▁Computed
▁interf
▁rhabdomy
obenz
tensives
cyst
opsy
▁Swed
▁detectable
▁daytime
▁3.5
▁angiotensin
▁peritoneal
▁(1000
▁efficac
opril
▁(71%)
▁hematologic
19
▁interventions
▁hydrogen
heum
itrate
▁resec
▁accounted
cholesterol
▁chorio
usively
ancomycin
lobin
mittent
ophag
▁tric
ologic
▁spacer
onide
▁arteriosus
astric
▁5%
▁coli
tory
▁circulatory
opause
▁malignant
▁spinal
▁13.3
▁sonographic
▁HbA
▁uncontrolled
▁quin
izin
▁68
▁qualitative
▁(8%)
▁hypog
▁Beta
▁flora
▁irritant
▁glomerul
▁resis
otox
▁noncom
rays
risk
▁contractions
jun
▁PCR
▁cephalosporin
▁valu
▁228
▁sensitivities
ejection
▁traction
▁duoden
oxicillin
thrombotic
▁ferrous
▁anticoagulant
▁estrogenic
triglycer
▁benign
▁euth
▁Trial
▁targeting
tipation
-72
▁(500
7,000
▁lidocaine
ophilic
▁arous
▁coh
▁menopause
elan
▁Thir
▁histopath
LV
▁coenzyme
ayers
▁131
▁0.17
ropath
▁tertiary
▁Neuro
▁atenolol
sparing
idation
▁clot
itin
itriptyline
▁implicated
teroids
▁pellets
▁standardization
yx
▁verapamil
▁FEV
encephal
▁cancers
▁shor
yses
ignific
▁adequ
Gy
olesterolemic
▁glutamic
tivities
6/
▁anticoag
▁nonresponders
istal
gol
▁93%
▁alopecia
▁renal
▁ratios
8-
▁0.45
▁esters
azepine
Bs
teral
onomic
▁withdrawn
ortal
▁tibia
▁Americ
▁50%,
▁hospitalized
lude
ypical
▁100,000
opathological
▁Acad
tiveness
▁chol
▁40,
▁BV
▁Benz
▁Incidence
▁0.1,
ocarcinoma
▁(46
tyl
▁8.3
▁propensity
▁gonorrh
▁pep
nine
onstric
▁bronchodilator
▁stepwise
eration
▁carcinomas
onset
▁5.4
▁caffeine
▁percentile
▁euthyroid
renal
▁0.5%
▁14.8
▁sequenced
▁derangement
▁defic
▁12,
odon
ymp
farction
▁expectancy
▁alanine
▁elicits
ogenic
▁Evidence
▁asymp
▁9.9
▁12.0
0%)
11.
roin
37
▁10.7
LU
odil
omiting
▁superficial
NH
-25
-13
ypro
▁precursors
ocin
▁embol
▁conges
▁anemic
-100%
▁extrac
▁uro
▁acids
▁CDC
cus
▁amiloride
Ti
inj
▁0.50
dose
▁121
amilies
5-
▁esophagus
havioral
effec
5,
▁lute
▁folate
▁80%.
▁biop
ositi
osomal
▁postinjection
osamine
▁181
9.
89
8,
▁insom
77
lies
athiop
▁ligation
▁modestly
▁Estrogen
▁Positive
▁persistently
▁(62
eces
7).
▁quantif
▁intramuscular
▁9,
▁cate
acrine
lobulin
▁deform
ifed
▁recor
▁cep
openia
▁56
tives
▁abdominal
▁melanoma
▁overestimated
▁Investig
▁sti
▁Insulin
ffeine
▁maternal
ophila
▁ADA
▁heterosexual
▁arose
cinolone
▁coag
erving
▁fasting
▁(67%)
-10.
▁plasm
omn
▁menopausal
▁ulnar
▁contradictory
▁0.016
izine
105
▁interferon
scop
▁37%
▁fetuses
▁dexamethasone
tingu
▁nondiabetic
.8%
▁Bac
▁depres
-1000
oscop
▁10%,
ermal
▁spasm
▁argues
▁acros
▁(3
▁21.
▁21
ceptive
▁benzodiazepines
▁tomography
controlled
▁doses
▁detecting
▁postnatal
amphen
robial
▁101
29
▁diastolic
▁56,
▁radiograph
ASA
▁INH
tracted
associated
▁attenuating
imus
▁VV
-50
▁gluten
▁16,
▁62
organism
▁comparisons
▁250
▁Prevalence
▁perforation
▁esophag
▁22%
▁nonselective
▁150,
▁cerv
surgical
▁15%.
▁interpretations
▁supple
450
▁133
▁postural
ethyl
-2
▁renders
▁encompass
0.
▁(50%
▁Chronic
▁microbi
7;
▁600
▁persisting
esic
▁differed
▁18,
▁neurologic
tures
▁CRP
▁resear
earance
▁exaggerated
▁1:
vity
▁confers
▁80-
▁voluntary
viron
▁0.59
▁pharmacy
▁naproxen
▁modif
▁infusions
4.
▁1%
3;
tel
▁regulating
▁12%
disciplinary
thmic
ovis
▁8.6
▁aqueous
4%)
invasive
threatening
▁verbal
▁excre
mortem
▁manifestations
"-
▁conditioning
▁0.03
▁admissions
▁EMA
▁237
▁splenectomy
▁vomiting
tents
Ta
iplinary
▁dosage
▁cys
▁perfor
▁endoscop
porting
uminal
▁hexa
stim
omann
▁(2),
▁5-
▁2%
▁lutein
tro
.4
▁titrated
▁goiter
▁72%
antial
▁unclear
omycin
▁0.83
acial
96
▁tended
▁subf
utable
▁perinatal
▁34
▁73%
▁surrogate
▁PV
▁lacks
intensity
▁genital
▁inges
▁emphasized
▁dihyd
▁17-
rocy
▁classify
stin
istar
roma
▁spon
▁hypothesize
▁7.2
tural
1%)
▁triad
titute
0%.
mmol
▁(15%)
▁128
thre
arrh
▁coagulation
▁0.99
-17
▁protec
▁enrol
anking
tually
inopril
ecia
▁infarct
▁cardi
▁0.10
thick
33
▁perfusion
▁adequately
ithium
▁predicting
▁referral
▁lor
▁0.94
▁compart
uracy
▁propionate
▁evid
▁(4%)
▁Ninety
-1.
▁carbam
▁6.9
▁117
erated
ifferen
▁quanti
▁78%
▁54
ovastatin
▁Mortality
▁atopic
iplin
▁dermal
eprazole
ipro
▁ingestion
▁amin
98
ithelial
vular
mol
jac
ophren
▁14%,
yrib
oprotein
▁duct
▁pressures
sors
▁glucocorticoids
▁simult
▁excision
▁competence
▁indus
▁nonpregnant
dil
▁6
mentation
topril
▁157
avir
▁Lymph
▁conclusive
potassium
retro
rosemide
▁retrospective
▁celiac
▁kinases
inally
▁couns
0.0
▁antid
ALT
thyroid
naud
▁nutritional
oag
vaginal
▁undergo
▁340
▁masked
▁undetermined
▁trimester
▁helical
irubin
-5)
otent
dia
▁mellitus
aric
thi
10-
tism
▁0.93
▁stres
▁Delayed
kely
▁ELISA
▁25%
▁3.3
▁toge
▁(31
▁transverse
▁hypertrophy
sistent
-6,
▁exud
hene
ilin
ulant
Fs
▁cann
HB
otransferase
▁epidemi
effectiveness
▁respiratory
▁Progesterone
▁(47
tivity
▁0.3
tec
▁readings
▁glycer
▁categorized
tioned
adication
troduction
oporotic
▁peroxide
▁(11
▁maneuvers
▁Patient
10,
otyp
▁4).
▁substitution
▁guinea
▁elec
▁154
▁amputation
▁pituitary
ardia
-79
▁Whereas
▁Initi
▁conduc
▁perit
achial
ureth
▁1.03
▁modalities
▁LV
▁estradiol
▁(4.8
▁recurrent
▁symptomatic
▁granul
opecia
ocysteine
lytic
▁IB
▁Lipid
▁pec
▁Compared
▁reproduc
▁responsive
▁uniquely
▁inconclusive
▁adjustment
gression
▁dex
▁1/
▁uptake
arachnoid
iscal
▁radiography
▁156
▁activator
▁Prel
▁8%
▁psoriatic
cad
entricular
4]
romes
▁315
▁granulomas
▁(28%)
▁suppressive
ectom
▁calcium
▁4.5
Cer
assi
4)
hospital
moking
▁7.5%
drome
difference
▁hydrolys
▁74%
tif
▁grading
▁fulfilled
/7
▁1.6-
2).
tors
▁13-
roscop
▁Epid
2-
▁rup
▁9.5
▁pts
entif
▁discriminate
AFP
▁uniformly
▁anesthesia
tation
▁contracep
ycin
rox
▁11.
▁OD
timulus
hemo
▁0.60
▁asymmetric
▁hyperch
▁foc
rane
▁nephropathy
molec
throm
onas
▁gluc
releasing
▁transferrin
ococcal
▁EI
16
▁autoantibody
▁PEG
▁151
onit
▁transthoracic
▁ect
▁bac
▁phenotype
oprim
ositive
▁titers
pine
▁Reduction
▁0.95
▁lymphadenopathy
17,
▁20-
▁antim
Pa
▁10.5
▁Sulf
▁favors
1.
▁dilatation
▁kidne
▁(1),
ditions
▁4000
▁4%
estions
directed
ystolic
▁exhibiting
▁bacterial
▁triglyceride
▁cutoff
amines
▁discontinu
▁unil
▁78
rachial
2.2
▁posi
ochrome
lyc
▁precordial
▁166
.8
▁1969
▁influenza
amn
▁0.5,
▁aspiration
hers
ropathy
▁preceding
stress
yel
▁shedding
▁febrile
▁gum
▁5.7
▁4.9
▁establ
▁223
▁echocardi
▁atrophy
▁surveyed
8;
▁morb
xiety
aline
odiaz
▁reduc
▁TI
▁Highly
esophageal
▁oxy
▁142
▁coordination
tizing
▁7.
▁conjunction
▁abnormally
▁frac
salt
ycline
▁evaluating
▁compositions
▁fibrillation
▁(84
-4
tens
expressed
▁slowing
▁8.8
▁BCG
▁demonstrable
ausea
0%,
ults
▁poisoning
▁203
▁intensive
▁99%
/18
▁preserving
36
▁multim
▁1-
piratory
ffec
▁superiority
▁discomfort
86
vival
▁conservatively
onidine
▁SPL
▁(60%)
▁50,000
rected
▁predictor
▁analges
erating
▁subgroups
▁Feeding
▁supplemented
▁antic
▁neoplasia
urrence
14,
umented
40
1).
6),
▁thyroid
diagnosed
▁IU
/1
▁endarterectomy
▁acet
gthen
▁(76
▁inversely
▁Hypertension
▁0.42
▁controver
▁underestimated
▁prescrib
▁Mast
ylated
sible
▁immun
00,
▁206
aryng
▁appendicitis
▁summ
▁Escherichia
olerance
osclerosis
▁uv
hydration
.0)
gestin
▁71
▁ablation
▁objec
▁80%
▁24-
▁80.
▁graded
▁appendic
▁Doppler
▁amo
▁cis
▁caloric
▁RAS
▁0.23
ergency
▁predic
▁reliability
ventricular
▁assessed
▁progression
rowth
inase
▁arth
uscular
oporosis
pregnant
atectomy
▁vesicles
ococcus
1),
83
thirds
▁clinics
▁systemic
▁leakage
azone
otoxicity
osclerotic
▁studi
▁extensor
▁abl
▁hemorrhagic
-18
tively
▁suppression
▁endometrial
▁6.6
▁proce
pecies
▁(49
esium
odop
▁complication
-9
▁nicot
5%
vely
▁preeclampsia
ectomies
▁fluoxetine
▁bilirubin
▁350
▁Replacement
▁8.2
▁incid
▁(33
10.
▁uncom
▁prednis
▁14
EG
herence
▁iatrogenic
comitant
▁lact
▁(5.0
▁subgroup
.4%
▁postprandial
apride
▁immunoblot
reast
▁sedative
ctomy
▁spas
coronary
▁inguinal
▁hered
oterol
▁polym
▁excretory
▁carbohydrates
▁194
▁Surve
▁judged
▁20.
▁hypothyroidism
oprol
ococci
▁91
53
▁herpes
▁extre
▁polyp
▁reticulocyte
▁posth
6%
uled
▁hematuria
▁warfarin
▁51%
▁benzodiazepine
▁ovaries
▁impairment
3/
▁wee
▁dysfunction
▁membran
aturated
ocardial
pation
acil
▁yeast
▁azathioprine
▁blocker
▁mono
osition
▁TDI
▁10
▁42%
pharmac
iotics
▁Sixty
▁3;
▁infusion
▁retic
oligo
▁amoxicillin
otriene
sied
▁angi
▁thems
▁airway
.2%
tering
establ
cepti
▁graf
▁(40
dip
xyl
▁emulsion
raine
▁effusion
traumatic
-78
▁Nit
▁glycol
▁11.2
▁benzyl
lox
▁vasoconstric
▁reversible
▁furosemide
▁Dental
▁attributable
▁10.8
atrial
▁0.20
▁1.9
etal
▁(3),
▁57%
▁ach
▁differe
emetic
▁LN
▁Prevention
dered
▁phleb
teric
▁(16
treatment
▁tib
oluble
tia
▁CI
tolerated
▁yielded
▁Transient
▁cla
▁examining
▁hygiene
toc
▁mitral
▁paren
▁Caucasian
▁118
▁Vitamin
acin
toxic
▁glycosylated
▁neonatal
▁regurgitation
▁scans
scher
▁chorionic
therapeutic
▁TS
▁succin
▁Retrospective
▁650
▁hepat
▁plaques
▁17%
▁cytoch
▁0.8
▁fati
▁75
osyl
▁stric
medicated
(4
▁infarctions
-90%
rogesterone
▁infectious
▁0.69
.0,
▁suppres
▁advan
▁aerobic
▁indi
quine
▁contrib
roxic
▁(150
▁Significantly
▁exag
▁colos
▁mening
lated
vaccin
tance
plants
▁chronically
tration
▁183
▁fibrosis
▁electrom
insulin
▁levodopa
exercise
-100
▁resol
▁167
oprostol
▁tolerability
▁definite
▁HLA
▁(1.6
▁maneu
▁(27
▁adenoid
▁83
azol
olesterol
▁quinacrine
▁193
trover
▁therapeutic
56
gestation
isolated
ritin
motic
▁1960
▁deoxyrib
▁reflecting
▁breaths
▁reversing
▁20%
▁glycemic
▁vaccination
Gi
▁20
▁herni
▁preoperative
▁longitudinal
▁hypoth
▁superf
▁LT
▁91%
▁Effic
▁ulcer
▁(5
duce
▁blinded
▁schedules
loro
etan
▁cyclical
▁ana
▁worsened
▁pharmacologic
Rs
tigo
▁107
reasing
▁plateau
▁hydrophilic
▁canc
1);
quit
▁modeled
▁endometrium
▁exacerb
▁perox
▁inflamm
athy
▁unaffected
▁9%
▁crom
▁increments
▁CAH
agin
▁17
▁inser
SMR
▁pneumonia
iminary
▁incision
▁dentures
flamm
▁ultras
▁nominal
▁prolactin
▁49%
ortic
reatine
▁(94
meth
▁HB
▁Respiratory
4.1
▁1,
edic
retic
▁insignificant
▁clonidine
▁227
ionate
▁saturated
▁pyrid
▁angina
▁isolates
▁severity
▁11.0
▁tenderness
▁0.12
▁33%
▁Pneum
▁valpro
▁1.00
erance
otypes
lyce
▁ureter
▁progressed
▁rhin
▁24
-52
▁visualization
▁7%,
▁salbutamol
▁genit
▁hep
▁subjective
▁latent
▁2/
▁intracerebral
▁(79
alian
▁36
▁Ig
▁poorer
▁perip
tency
▁constituted
▁15.
▁glut
▁70-
▁predisposition
▁glucocortic
atally
ostatic
▁microorganisms
▁Screening
▁Evaluation
▁subjec
)],
▁paroxysmal
partic
▁bipolar
weighted
▁2.7
fal
12
▁inhibit
usp
-88
stem
ections
▁retin
▁dissemin
▁(8
▁tumor
particularly
▁interacted
-7
omatic
▁6,
44
▁exercising
▁(3)
▁hypotonic
▁physici
▁efficacious
▁intest
▁Risk
▁referrals
mur
▁(1:
ophyll
▁grise
▁gastroenteritis
otrexate
oneph
▁modifying
▁ranitidine
▁curric
▁20,
68
▁vein
ophys
aminase
▁decreased
▁chloramphenicol
%),
▁0.11
▁24)
▁prophylaxis
▁ofloxacin
▁nonsignificant
leuk
▁solitary
/24
feron
▁CAD
▁acces
▁bacteremia
▁tumors
▁cefaclor
▁illnesses
vaccinated
▁dosages
▁0.1
LR
▁-1
▁0.07
▁neurogenic
ardias
opamine
lact
▁Hib
immune
▁metastases
histamine
ressing
▁benz
▁mcg
▁epilepsy
tisone
▁durations
trates
▁spor
▁capsaicin
cemic
▁(1.2
ionic
vivors
▁substances
▁derange
onary
▁recom
▁59
vastatin
▁orally
/6
enters
ogl
▁hereditary
▁20%,
micro
gA
▁Abnormal
▁cardiac
▁defects
▁0.34
sA
▁prescribing
▁5.2
▁acetic
▁gradual
▁transmitted
▁0.56
▁genotypes
▁152
▁ramipril
unctional
▁158
▁parental
▁chlamydial
▁pooled
▁doubled
tran
tage
uitable
trac
▁carp
tations
ometh
▁sple
oxyrib
mL
▁serological
▁Depending
umbers
lycer
▁undere
▁diarrh
▁lipids
▁myc
2%
▁concurrent
mediately
▁0.58
▁testicular
▁membranes
disc
.5%
osus
▁pylori
▁90.
▁intravenous
tant
▁12.5%
▁immunotherapy
▁hemorrh
▁deterior
▁Acet
▁124
omyces
sion
▁sickness
ranolol
▁255
▁produc
▁hydrox
▁hypnotic
▁naf
▁nylon
▁residual
▁90%,
▁metformin
7,
▁(23
▁cholest
▁glycos
SAID
tam
otting
agonists
▁resul
▁56%
ipid
▁5.6
▁orthoped
atches
▁84
▁horiz
▁pulses
▁intraepithelial
▁Oral
▁5%,
▁spleens
mature
▁(38
▁provoke
▁HI
▁2.7%
▁mice
▁puncture
▁26
acids
54
anin
gesterone
.2
▁repro
38
▁52
▁hazard
piration
▁imaged
▁infertile
▁glucocorticoid
300
▁(44
▁indeterminate
▁0.87
▁sorbitol
▁promptly
▁Measure
ocor
oracic
▁Injection
▁thiazide
apine
▁obesity
▁grouped
▁LDL
ventilation
▁oss
▁limb
▁symptom
▁perin
▁bronchitis
▁Hg
▁deterioration
▁stimul
▁0%
▁Extensive
▁cutaneous
▁recurred
▁18.
▁(4-
▁psychomotor
▁115
▁specificities
▁sorb
relaxation
8)
▁11.8
▁Medicare
-65
cyclic
▁0.78
▁presentations
▁dermat
itamin
phor
▁occurrence
▁nasal
▁Calcium
▁15%
▁parox
eeding
▁congenital
(2
▁(45%)
hydramine
50
trical
▁fertile
▁depressive
4),
▁inhal
yrid
bral
▁cic
tical
▁progn
▁0.75
▁0.55
▁Leuk
atical
▁0.3%
fir
▁Prospective
▁termination
11
▁0.88
actam
▁androgenic
duction
5.
rein
▁2.6
▁(4.0
▁100-
owel
ogenous
▁uterine
▁30%,
ofib
▁8.0
turb
tib
▁40%.
▁cerebral
ysts
▁antipsych
IH
▁consecu
▁methodological
ochrom
▁ultr
tebral
▁histamine
▁respir
▁averaging
otoxic
▁actin
illar
▁cereb
▁neurolep
gm
vus
▁6%
▁allergy
gia
iability
▁-0.6
ervations
osol
compared
fat
▁spikes
▁regimens
▁Lact
▁ultrasonography
▁bromocriptine
▁ABR
osts
phosph
AO
▁intram
coh
▁congestion
partate
stimulating
▁microscopic
drug
▁subsets
▁lithium
generation
6,
▁bradycardia
▁untrained
▁prospective
▁antidepress
erate
avail
erge
▁chorion
▁equivalents
blood
▁hyperthyroidism
▁(4)
30,
sies
▁94
tte
▁60-
oxyl
▁3-
▁colic
▁fetus
▁mep
▁esophagitis
84
▁terat
▁12
▁noc
ocyte
roat
▁tolerate
▁74
▁recruited
▁occupational
tices
▁14-
ocl
▁abstinence
▁(1.5
▁thyroiditis
acet
▁trig
▁77
▁-0.7
3.
▁(50%)
ometri
▁aerosol
▁cured
pirone
lipid
▁inherent
▁195
oxid
orin
intestinal
tative
gluc
▁amitriptyline
▁unselected
organic
2)
▁0.2,
▁CG
▁gynec
▁38
51
fusion
▁urtic
tions
trimester
bility
▁subc
ocytosis
epsia
▁-5
ithm
epines
▁carc
▁weighted
▁indefinite
▁preexisting
▁99
▁pla
idating
timulation
▁compares
▁incom
▁backgrounds
ospor
▁nonsteroidal
▁uncomplicated
▁Estim
▁800
venty
▁undetected
▁renin
▁extracorporeal
▁anomaly
▁angiography
▁colitis
achnoid
▁twofold
onor
PCR
▁irritation
administered
▁alp
reases
▁instrumented
▁incontinence
▁49,
▁50
▁induc
nai
322
mokers
▁Individuals
▁pancreatic
▁steroid
▁66%
▁pneumococcal
▁triazolam
▁ciprofloxacin
▁reinforcement
▁dietary
▁104
▁Statistically
▁61%
poor
▁possi
▁articular
tron
ipit
greater
ophy
▁stimulants
▁identifiable
iological
9),
▁exploratory
▁(1.3
▁inversion
ovarian
▁adhered
▁0.46
▁106
▁clues
umably
phal
▁Hyper
urban
▁anat
-20%
ariate
40)
▁270
omotor
▁110
▁Diabetic
▁Nons
ylene
within
▁Abnormalities
▁134
ocrom
▁discharged
▁3000
▁preschool
ophilus
parathyroid
▁attenuation
inic
▁chloride
9%)
▁endoc
▁1.9%
400
▁1.25
▁colonoscopy
▁Symptom
0.8
▁quantitative
yste
▁spirometry
▁histology
▁unilateral
▁97
▁ascorbic
rals
▁cephal
▁latency
clinical
▁lumen
umbar
ongest
Cs
▁percentages
▁glyc
▁ischemic
-22
oconstric
etoprotein
▁brainstem
ocyt
▁clind
▁Epidemi
early
▁quantit
chlorothiazide
▁asthma
▁techniqu
▁calf
▁repor
▁minus
▁UTI
▁Caucasians
asses
▁Increas
spective
urin
othi
▁13.
▁aureus
▁miti
ecal
ocellular
ureus
▁Rout
atural
▁creatine
ophysical
▁122
▁55%
▁antidepressant
▁(90%)
▁acqui
▁linearly
▁arthritis
▁allele
ystitis
/3
▁6.
pain
tus
merc
▁13%
▁intolerance
▁musc
▁Combin
▁autoantibodies
▁satisfactorily
▁neuropathy
▁encephalopathy
▁Likewise
▁bladders
▁(1).
▁postoperative
urrent
▁(9%)
▁70%
0,
▁obstructive
▁200,000
kage
▁Regarding
▁ank
▁9.7
▁186
perature
▁favorably
▁thrombocyt
▁(0.0
▁persisted
▁testis
▁arrhythmic
94
▁struc
▁spontaneous
▁chlor
▁0.26
▁nonsur
▁sten
▁Angiotensin
200
▁carbohydrate
-24
▁(250
▁0.24
▁revascular
▁isoniazid
ohns
tero
▁placental
▁119
feeding
▁jaund
▁teratogenic
▁subclinical
34
▁substanti
▁atypical
bodies
havi
▁intran
▁40%,
▁CABG
uran
IU
▁CIN
▁discontinued
GH
ocar
opi
▁juven
▁transplant
ominant
12-
idis
▁psychiatric
▁42
atab
proven
adders
▁counseling
▁eccentric
▁12.5
▁vitro
gth
▁2.5-
▁polysaccharide
alb
estis
▁0.38
▁28
trop
▁tes
▁expec
▁100%
▁elective
▁acutely
▁persis
▁pate
tility
tur
▁81
▁Injury
certain
▁nasopharyngeal
vac
▁1.
eclamp
imentation
▁secretagogues
erver
.9%)
pharyngeal
,000
ampl
▁inh
▁172
▁Stro
▁vegetable
▁4-5
▁postmenopausal
▁105
▁hypokalemia
-8
otre
▁cyc
▁ulcers
▁simultaneous
▁Relative
urgery
yridine
olig
▁Subsequent
▁(0.5
▁opioids
▁anatomic
ymptomatic
▁meperidine
3)
▁147
▁90
onate
32
▁1.6%
▁inhibitor
▁132
operative
▁succes
▁20,000
onucle
irc
lux
▁antagon
uling
▁pancre
significant
▁deox
ticular
▁86%
imin
ocalization
▁sequentially
8%)
wk
inflammatory
yroxine
adily
▁classifications
▁116
▁carbonic
igl
ensitivity
2/
▁cyclo
etence
▁pea
▁MRSA
1,
▁Chlamydia
▁testosterone
▁82%
▁continuation
▁estrogens
▁lith
oplasty
▁12%,
▁140
▁manifested
▁hairy
▁HS
▁assessments
tein
severe
ported
▁212
median
ureas
▁erythema
iasis
▁Myc
vaccination
▁adjus
oagulation
▁erythrocyte
meter
opr
blind
atitis
tate
-96
▁soy
▁elevate
kelihood
▁audi
▁Preliminary
▁1987
enil
▁fibr
▁vaginal
arate
▁ascertain
notic
▁concomitant
▁sampl
▁gestational
▁Inventory
neumon
▁psychosocial
▁acute
▁Duc
▁palsy
1]
▁PGA
osacral
▁heavi
adone
icin
▁relaxant
▁subdural
▁identi
thma
▁microvascular
enteritis
utaneous
▁Ib
hion
▁postpartum
▁colpos
▁previ
▁apnea
▁1.06
oxin
-]
▁(12.5
▁biopsies
▁transformations
▁responsiveness
.0%
.7%
▁experimentally
azepam
ayed
▁normotensive
▁Specificity
atoid
0)
▁biphasic
▁(97
▁beha
▁1.5%
ths
▁dyspnea
▁1.5
atosis
osage
▁229
▁(5%
▁heavier
lac
troph
▁(0.
▁differentiate
▁arteri
▁Gonad
▁progesterone
chid
bacco
▁internally
▁thre
concentration
oretic
cis
▁trac
rele
hyd
▁inflammation
▁standardized
▁0.29
▁46
anat
▁Consequently
▁ovarian
25,
▁digoxin
8]
rofen
▁carbamazepine
▁instruc
vents
▁vitamin
▁(2)
81
ticle
7),
▁traumatic
▁direc
▁investigators
idated
▁compartments
▁ICU
61
▁ferritin
3,
endazole
▁colonization
▁(17
▁3).
▁elastic
▁therapies
64
▁embolism
▁blin
▁monit
▁necrotizing
▁osteoarthritis
▁0.80
geal
▁mEq
valence
▁hydrochloride
▁uteri
iuria
cence
▁209
plas
▁increas
/20
aturity
onatal
▁intermittent
▁transaminase
▁2.2
onc
▁confounding
▁amniotic
-70%
onin
▁aden
yroid
etaz
▁specialty
tinent
▁adenomas
▁smokers
Gs
▁gonadotropin
exposed
▁51
▁diagnoses
sue
▁2.4
▁suture
▁anhydrase
▁decreasing
xone
ameters
▁incompletely
eptic
measured
▁198
▁antifungal
▁ultrason
▁20%.
▁autosomal
▁improves
▁TSH
▁ventilation
▁erg
vascular
▁relieve
▁requi
▁atten
itro
▁diagnose
929
91
▁birthweight
50,
tially
teria
▁cephalosporins
▁seropositive
▁exceeded
atell
▁colectomy
blocker
contrast
erent
▁abor
molar
▁1.1
▁correlating
▁(0.6
actin
▁buspirone
▁asthmatic
▁nonp
▁headaches
taz
▁optimum
▁bismuth
▁30-
acquired
▁50-
▁penicillin
▁adipocytes
ritish
▁diarrhea
▁Urine
ospasm
▁elimin
inesterase
-7.
▁Arter
uprofen
▁contaminated
lec
▁splenomegaly
▁mec
▁necro
▁calculi
▁8
▁0.1%
lep
omal
▁4.0
▁60%.
▁thyroidectomy
▁effic
▁homogeneity
sul
▁Adverse
▁atrial
▁59%
▁nodules
odine
lodipine
▁vulgaris
ectomy
▁irrig
enyl
▁vaccinated
WB
valine
▁proximal
▁antigen
▁10.2
acted
▁75%,
▁OA
antibody
60
epine
▁prednisone
▁dextro
umerous
▁40
regn
erable
▁2)
▁duc
0%),
opro
▁25-
lamy
atum
▁antibody
▁biopsy
▁underg
apamil
▁chemotherapy
▁gonadotrop
▁Failure
tent
42
▁transient
oderm
▁mammography
▁ECGs
selec
arcin
faction
sions
▁effec
▁NSAID
▁pigment
▁imaging
▁nifedipine
loxacin
▁physiology
-0.
▁desaturation
▁positioning
▁splenic
▁delaying
▁47%
dle
▁ecz
▁fluoride
▁reac
▁2.6%
▁untreated
gment
omegaly
▁penile
▁regulate
▁25,
baseline
▁13,
▁leukotri
▁58%
facturing
▁beats
▁146
▁ulc
cious
▁confirms
erb
Ig
/8
trol
▁AO
▁hypothyroid
90
▁anaerobic
▁2.8
▁ejection
deriv
omethacin
ulitis
▁ejac
-12
ods
▁acyclovir
flammatory
plementation
spar
▁(25
-1.0
▁renovascular
▁thromboemb
▁bladder
▁137
▁3.8
▁onset
opa
▁enrolled
▁glomerular
▁construc
ipr
▁erosion
▁logistic
▁antioxid
-16
ograms
0.9
echn
▁quadrup
torchid
osin
-5
▁promp
vian
▁colonic
▁lateral
SDS
▁plas
▁bicarbonate
▁0.51
▁155
▁radiographic
anine
resistant
▁worsening
▁Bec
▁compli
.9
hydr
▁sput
▁spre
▁Twelve
Ca
140
▁serology
oil
▁(45
▁shortened
▁adjusting
▁sucralfate
▁inhibitory
roxyprogesterone
▁cultured
▁prodrug
lysis
esia
▁abr
▁scre
▁bran
▁atropine
▁panc
▁murmur
▁NSAIDs
▁(93
▁(77%)
▁anticoagulation
▁58
▁antipsychotic
tropine
tice
▁compartment
▁Survival
▁exis
entile
atropium
-3.0
▁0.64
odic
▁intranasal
▁malabsorption
yrox
quired
▁cyclosporine
▁-15
▁parathyroid
90)
▁aluminum
14)
▁modality
▁hepatotoxicity
(3
opathology
atrop
4).
▁50%
zyme
traum
▁bactere
▁preventive
▁0.6
▁malignancies
000.
▁prophylactic
lives
▁chec
▁ery
blockers
-19
▁theore
orac
▁prolongs
▁1.2,
▁0.81
▁(21
▁(10
▁0.33
▁swabs
aceous
3).
▁400
lys
vant
▁prol
▁torsion
▁prematurity
▁diabe
▁gyn
uretics
wes
▁1.05
▁revised
▁stools
▁196
▁(7
▁111
▁84%
▁synthesize
▁1.2
ibrate
▁constipation
▁antioxidants
BH
enic
▁nadir
▁distal
cysteine
▁neomycin
▁impairs
/9
▁osteoporosis
razolam
▁Thirty
▁hyperglycemia
▁HL
▁monitored
▁surrog
▁200-
▁Ade
▁critically
▁waking
▁0.05%
▁invasive
▁outflow
▁hyperp
hydropyridine
▁monotherapy
▁stimulus
repres
▁newborn
udin
osteroids
▁-3
▁gentamicin
oidal
▁eradication
▁epidural
▁-0.5
▁cytologic
▁tuberc
etent
itively
tically
▁inten
atient
▁surgically
▁endo
▁Haem
▁HPV
phil
▁Viral
▁Bacterial
▁awak
othiaz
▁87%
▁carpal
▁8.1
▁intra
▁94%
▁(300
▁squamous
yro
▁contraceptive
sive
▁5.
▁31,
▁Barrett
amus
▁incub
▁questionnaire
▁antagonist
▁examin
▁neph
▁MH
▁attain
5]
▁Estimates
dic
▁perone
occal
amycin
enteric
▁glands
CHD
▁pneumoniae
ration
▁suppressed
▁postoperatively
echan
▁tec
acting
▁pharmacists
visc
temperature
▁sugars
7)
acental
▁43%
▁750
▁vancomycin
▁65%
respective
▁Ure
▁erythematosus
▁elevated
ilateral
▁11.5
500
93
▁Subcutaneous
▁antich
▁hypon
▁bic
imination
▁pulmonary
▁apne
induc
▁144
▁Assessment
▁inflamed
▁peaked
produc
methyl
▁eighth
▁LMW
leu
▁adjustments
osocial
▁0.62
▁combin
▁poin
▁Increased
phine
▁proceeded
Tu
abdominal
▁86
thood
▁skeletal
ometrial
reas
examin
▁4.8
▁placenta
▁23,
fib
▁phon
aind
65
▁sut
▁weakly
▁hypoxic
tention
▁vitamins
▁pyridoxine
▁gonadotrophin
-20
▁(67
▁Stress
erative
▁discon
ture
igaret
.0
iclovir
fec
DV
chers
▁antis
▁thrombo
▁creatinine
adic
▁covari
▁injec
▁transcription
ocaine
▁95
▁skinfold
▁practitioner
▁retinal
▁163
▁fathers
athioprine
▁hyponatremia
▁Clinic
▁90%.
oxif
fractions
alp
▁calcified
7.
▁anomal
▁triglycer
▁characteris
0.4
▁114
▁inpatients
stab
▁hypothal
▁cromoglycate
▁rifampin
ociated
▁antagonists
▁norfloxacin
tection
▁cortisol
▁resonance
▁sutures
uric
rowing
illary
otine
uting
▁reflux
▁cortisone
illi
▁19
olated
mented
traction
rease
▁incomp
74
5;
▁potent
▁neutropenia
▁exce
▁obstruction
▁pyl
▁97%
romal
▁incidence
brile
induced
▁Fib
-2)
acterial
▁hygi
▁(78%)
uretic
arial
imazole
▁laparoscopy
▁mucos
ytes
▁causal
▁refractory
▁3.6
▁10,000
▁DMP
▁ketoconazole
▁31
iol
▁immunocomp
▁hypotension
▁hyperg
otropin
▁concordance
▁adversely
▁Combination
▁agonist
▁abnormal
▁tracts
▁amp
▁4.7
▁accid
▁16%
▁acupuncture
▁reliably
ontal
▁inducer
▁salivary
▁14.5
▁Eighty
▁tac
▁elevation
▁sequelae
▁CAP
▁metoclopramide
▁sepsis
130
▁diphen
▁RR
▁reinfection
▁60.
omat
▁noninvasive
oyl
casein
endix
▁emesis
▁Magnetic
▁simplified
jected
andard
.6,
▁malign
orotic
administration
▁85%
gus
unar
sibly
▁suscepti
▁pharmacokinetic
▁saliv
▁persists
amol
sives
▁intrap
oscopy
▁(10.
▁90-
xime
▁SPF
▁1.02
olam
55
▁trichloroacetic
▁hormone
▁Significant
▁endotracheal
▁methadone
▁maturity
▁(25%)
orh
▁analyses
▁(72
▁dehyd
▁Leu
▁6.3
▁amph
▁1.8
▁48-
hap
%).
▁hypertensive
▁relapse
▁sedim
▁fla
reactive
-0
PPP
ecretory
ipheral
▁Thyroid
▁Pregn
▁lability
choles
▁dus
▁3.1
▁protr
▁AFP
▁(86%)
oride
ocusing
▁progestin
▁estrogen
ulose
▁Diagn
aryl
gestrel
ealand
▁musculoskeletal
▁gastric
▁arterial
lora
▁hypothe
▁gland
▁obstetr
buterol
ferrin
rotal
EI
▁glomer
▁0.14
▁paroxys
▁plasmin
-6
▁Suc
responsive
▁45%
▁basal
▁Myocardial
9%
tide
▁Calc
▁disclosed
iae
▁receptors
▁ventilator
▁enteric
▁23%
taining
▁218
▁gly
▁0.7%
▁appropriately
▁87
okinetic
ducts
▁mell
uin
▁9
▁(2
▁polyc
▁absorptiometry
▁3.0
▁genotype
alsy
junction
▁drainage
retion
▁behavioral
▁evol
odal
▁postnatally
▁reflec
triglycerid
▁ND
6%)
trib
ventive
▁fluor
uted
▁predis
tir
▁DBP
▁6.2
▁assays
▁0.57
onine
qui
800
▁pertussis
iparous
1-
▁correlates
▁receptive
0%
▁(85%)
amet
5),
▁analgesia
ophen
IgM
▁Tissue
tive
▁imipramine
5%,
▁5.1
▁endocrin
▁pathology
▁sensitiz
embry
▁ecological
/1000
Ts
▁27
▁nocturnal
edema
tested
▁peripheral
▁Hyp
▁(50
▁Atrial
▁249
▁0.36
▁TCA
▁recurrence
▁0.41
▁thi
▁Complications
▁electrolyte
pregn
▁Thirteen
sia
▁Staphylococcus
▁sham
▁differentiated
▁evaluates
▁multicenter
▁practitioners
tinguish
▁carotid
Ep
▁molecule
eared
opian
itus
opausal
▁RS
tise
▁titration
▁18%
▁washout
▁GER
molality
▁initiation
▁obese
▁osteoporotic
▁fibros
▁30
-2.0
▁exclusion
9)
gulation
▁prostatic
▁cysts
▁Higher
▁synovial
▁caregi
▁cohorts
▁40-
▁aerob
estrogen
idine
bly
▁enamel
duced
▁Afric
ordance
amilton
▁Oste
ighted
0.2
▁islet
-40%
▁54%
▁135
▁0.72
enia
▁(24%)
▁immunos
▁abscess
▁commercially
▁encomp
posable
sequent
cine
8),
retin
fine
▁reticul
prandial
▁pem
▁8.
bearing
▁alternating
▁recr
▁188
zine
erally
▁MIC
-35
▁suction
▁undergone
amethoxazole
▁lymph
▁0.67
▁5.3
▁0.90
▁eryth
43
terin
opulation
22,
jury
▁120
0.7
essive
usually
▁(26
▁3.2
▁Sensitivity
▁occl
▁retinoids
ergenic
▁lacked
▁microb
30
▁197
fiber
ymptom
▁circumference
▁45
▁randomized
▁triceps
▁consis
2.
▁Gluc
▁15,
▁serotoninergic
9;
▁aggression
converting
▁Gyn
ovirus
▁absorpti
▁hypokal
erop
otor
erum
▁hypoglycemia
uplex
▁antec
▁hepatomegaly
▁reactivity
bran
▁infections
tite
▁20)
zard
▁0.25
▁Exc
▁103
edle
othal
adjusted
organisms
▁addic
▁hypothetical
▁1.75
▁inhibitors
▁clamp
▁singleton
▁malformations
▁Findings
ispanic
▁arter
acute
iline
PaO
23
▁aids
oppler
▁DCA
enem
▁IVC
▁auditory
ulcer
achol
▁ppm
▁intrauterine
omies
lamp
▁converting
-600
oscopic
lycemia
▁Factor
▁(7%)
▁ductus
olus
romycin
▁chlorhexidine
▁43
▁Specifically
▁(4
▁gon
antibodies
ameter
▁cyt
carotene
▁duodenal
coag
3%)
uccess
ipramine
oprolol
▁sedation
urred
4;
-8,
▁gestation
▁damaging
ipolar
▁3%
▁cryp
▁48
▁diuretics
▁13
ediatric
▁questionnai
▁(62%)
embran
▁6.4
▁nosocomial
▁dementia
▁emboli
atation
CRP
alc
▁vigorous
▁67
feren
▁drinkers
▁hemorrhage
ductive
aginal
▁morphine
▁241
chloride
▁probes
▁plantar
▁100
▁unexpectedly
umetanide
▁ranged
aternal
▁35%
▁saphenous
▁conflicting
▁bilateral
▁preparations
▁accep
▁retrospectively
▁comple
▁urea
either
▁piroxicam
-1)
trast
thmatic
▁47
zymes
adine
▁predominantly
2,
▁0.74
▁ampicillin
▁selec
▁disturbances
(1
▁2.5,
▁nontoxic
▁micros
▁persist
▁impaired
▁21,
hydrop
▁filtration
▁valve
24,
▁Hyd
▁440
ints
▁insufficient
▁assis
▁avoidance
▁Multiple
oplasm
▁pharmac
▁localized
▁implying
▁biochemical
▁hyperthyroid
21)
trin
▁hypop
-4.
▁sci
▁ligament
0),
▁ischemia
lyl
Hb
viral
inergic
6.
▁adop
▁LVH
▁pancreatitis
▁pretreatment
chool
▁yielding
▁0.2
reported
ralfate
placebo
▁fixation
▁bioavailability
▁bronchoscopy
indings
▁dipyridamole
▁corticosteroids
▁39%
▁resour
exin
▁ventil
▁5.5
▁bypass
tussis
▁1.15
▁sedimentation
▁tran
rocyte
▁suicidal
▁9.0
▁immunogenic
▁256
▁validated
▁10.0
▁cervical
▁heparin
▁79%
▁neurop
▁Intr
▁indo
▁deviation
▁decarbox
▁angioplasty
▁(18%)
▁hemorrhages
▁statistically
▁topical
▁PMS
▁expiratory
▁adenocarcinoma
-6.
▁arrhythmia
cephalic
▁Streptococcus
▁oxygenation
▁differen
ludes
25)
luded
70)
cutaneous
arynx
▁satur
▁ionized
▁0.2-
31
arbox
onam
▁prospectively
▁contraception
eak
▁200
tum
itudinal
▁CN
versely
▁allevi
▁(32
▁nitro
▁nonfatal
1/
▁108
▁identif
▁insoluble
▁(15
▁complications
-90
▁173
▁enzyme
▁airflow
portant
▁enlargement
▁bathing
etine
endi
▁(3%)
▁nonc
▁HDL
▁bir
apid
▁7.5
▁intrac
▁Improvement
ioid
▁concep
▁2.3
▁leukocyte
▁biased
▁intercourse
▁immunized
▁Fourteen
▁functionally
▁sulf
(6
▁enhances
thmias
uality
▁2.0
▁concurrently
▁stringent
tional
▁whee
▁mIU
▁Steroid
▁185
▁arrhythm
▁doubling
ficial
▁dias
▁infarction
odiazepine
▁sexually
▁decayed
▁pati
dL
arean
▁rectal
tial
▁heterogeneity
▁diabetic
.10
▁rhe
-15
▁unreliable
ungal
▁(5%)
▁drin
aminophen
▁evacuation
Ox
▁lifest
▁doxycycline
lier
▁(58%)
▁Finnish
▁Secondary
▁analgesic
▁fossa
▁paral
▁malignancy
▁kidney
▁physiological
tense
▁venography
1;
▁16.
▁52%
▁bumetanide
▁anteced
▁tuber
▁overlapped
▁thereafter
/2
▁55
▁deformities
ischemic
▁bism
▁dehydration
▁manu
▁11
▁oximetry
▁diagnosing
-125
uble
45
▁tamoxifen
azoline
hydro
diabetic
ergic
▁HBsAg
angiotensin
▁Fifty
▁88%
▁aberrant
▁OC
-3.
▁Alzheimer
▁98
▁(0
▁optimally
▁routinely
ithi
tiguous
aund
▁Transi
▁unfractionated
vated
responding
▁0.91
▁55-
ertion
48
spectrum
▁pyel
andida
▁192
▁64%
▁predictors
agonist
▁formulation
▁tymp
tropin
▁0.30
▁0.35
▁streptococci
osom
▁excised
▁0.79
▁heterogene
▁outlet
▁thromb
▁opioid
▁urinary
▁0.4
aemic
epam
▁nodule
▁validity
Ls
▁reflex
ocytopenia
▁intractable
umping
acr
▁ethn
titis
▁pH
▁adulthood
67
▁initiate
▁cros
▁eliminating
▁favorable
▁Depression
▁0.5
▁Elevated
xia
tigu
owever
letion
omized
72
▁injur
etus
▁Nine
umulative
tening
▁emerg
ventional
▁exceptionally
/100
years
0.5
odia
▁predominant
oic
▁7.8
▁76
▁occlusive
▁ECG
dural
▁hypercal
▁11%
ochemical
▁paradoxical
sensitivity
/10
▁ascorb
▁70
gents
0).
▁erythromycin
NIDDM
Cy
ilol
▁Cumulative
kine
▁alb
pir
tensin
bacter
▁EB
▁susceptibility
▁1.7%
▁(92
▁dye
▁46%
▁toxicity
▁27%
ximal
▁nip
IgA
▁21%
▁longus
▁marginally
razole
▁seronegative
aturation
▁interleukin
ocys
▁radiological
▁49
▁favoring
▁comparative
▁detec
▁vascular
▁cyclooxygenase
▁3.7
▁cerebro
▁perce
▁10%
▁syndromes
orbid
▁cen
▁infants
ipine
▁endpoints
▁NP
▁warr
ffin
▁cerebrovascular
▁pneumon
▁MMS
enin
▁dysp
69
▁analogue
-80
▁dopamine
-36
ilus
azep
▁insertion
attern
▁80,
neph
-2.5
ituit
eric
▁cruc
androgen
▁89%
teroid
lowering
▁1966
coated
elvic
▁multivariate
▁lactation
▁rheum
clic
▁schizophrenia
▁ure
▁clomiphene
lym
▁(56
upuncture
esting
ternational
▁orthostatic
▁corticosteroid
iteal
▁artery
▁remission
itoring
▁LM
▁130
▁femoral
▁PCO
▁gels
ysm
▁contiguous
▁19%
▁Smoking
▁2.8%
▁isch
opar
esti
olytic
▁distinguishing
▁elemental
▁sulfate
21
brom
opramide
▁selective
▁0.15
sodium
7%
▁mildly
ilep
▁inadequ
butamol
▁observational
▁certainty
imeth
▁75%
sibility
▁quotient
LN
▁Alz
▁7
LH
▁lupus
87
▁physi
▁serotypes
-60
▁213
rents
▁Sixteen
heat
urea
▁adolescents
▁rhy
▁Behavioral
▁seb
▁anesthetic
▁positively
▁31%
tally
timal
▁Exercise
▁(10%
eptide
▁tubercul
▁Candida
▁264
▁0.54
ucle
ordin
▁blot
odds
-34
▁balloon
▁25
-23
▁neoplasm
0.00
gic
0%).
▁Comparative
▁glucose
ergen
▁retard
genic
▁metronidazole
articular
aminated
▁elevating
▁multis
▁Scale
▁regurg
▁lis
▁139
asic
▁cranial
▁stu
▁moderately
hydrox
din
▁theoretically
▁regression
▁muscul
▁usefulness
▁28%
▁neuroleptic
▁PEF
-66
▁fulmin
▁Nineteen
▁antithrombotic
▁indications
▁concentrations
82
▁scalp
▁hypogonad
▁4.6
▁induce
dine
▁gout
▁4.2
ignant
▁infrared
▁expressing
▁analgesics
ffe
▁antibiotics
▁tendon
▁DF
uestion
▁wards
buride
▁calcification
olism
welling
▁quantified
atif
olamine
mend
▁crossover
oratory
cyt
▁elimination
pecially
▁fluconazole
▁1.08
▁cholinesterase
73
▁stenosis
▁multiv
▁Thy
ocomial
hig
▁quoti
ritic
idespread
▁cavity
127
(5
adian
▁occult
▁radionuclide
57
▁preterm
▁(18
albuminuria
went
ulla
▁comprised
antoin
▁grains
▁Assess
▁capsule
▁112
▁cholesterol
▁reductions
horm
oskeletal
▁trimethoprim
▁pectin
▁(95%
52
▁pulmon
▁abdomen
88
▁unex
▁supplementation
▁Meas
▁desm
onazole
▁socioeconomic
▁traum
▁adverse
hypertensive
▁mU
tinu
▁126
:1
▁uterus
.5
▁memb
▁systematically
▁235
▁(16%)
▁buc
▁Increasing
▁characterizes
▁encephal
rotein
▁2.5%
▁1980
▁Coronary
▁Tran
▁BMI
▁bup
epti
▁CHD
▁allergic
▁yearly
▁recordings
▁4.4
▁autoimmune
tic
indol
▁-12
20
▁leuk
roxicam
▁PLP
▁acidic
▁insulin
▁tibial
▁hydrocortisone
▁deficit
▁chlorpromazine
valent
arrhy
▁antimic
▁sulfoxide
ylase
▁cef
entified
95
10
▁nonin
iagn
▁vesicle
▁(70
cellent
oxazole
nec
▁Eleven
opo
▁jaundice
▁demonstrates
▁surgeons
iazide
▁Reduc
▁markers
▁3
▁tox
FSH
idin
▁Therapy
▁unnecess
▁screened
plemented
▁hypo
average
▁39,
epithelial
▁TC
▁unrelated
▁10.
abd
patients
▁intub
ventil
▁congestive
▁82
imens
▁microscop
▁fum
tual
▁Infants
▁233
▁initiating
▁fumarate
▁1970
phosphon
▁1.12
allium
700
▁perc
ximum
▁(3.0
▁discriminant
▁echocardiogram
▁psycho
▁Ps
utin
ected
rosy
▁cesarean
iotensin
▁capillary
▁thresholds
▁sulfonyl
▁menstrual
ographically
▁decarboxylase
▁sediment
▁serologic
▁enl
▁9.2
▁abnormalities
▁investigations
tified
essation
▁milder
▁metoprolol
terone
tivation
ailure
▁outpatients
uestionnaire
entical
-45
onyl
amuscular
▁239
▁6.5
▁detects
▁61
▁4-
▁pathophysiology
▁underst
▁43,
affec
terase
acerb
▁Histologic
▁3/
:1)
itant
▁gradi
Ba
orrh
irone
▁solit
▁affec
effects
▁indicators
ithromycin
-1.5
▁outpatient
▁3,
gely
biotic
ithin
olitis
▁0.6%
trum
▁overweight
▁67%
reactivity
▁prescriptions
▁70%.
▁neurotrans
▁Bronch
accharide
inyl
▁expres
▁omeprazole
ichia
lovir
nons
▁amenorrhea
gressive
▁LR
▁correspondingly
103
▁tablets
entia
76
orrhea
▁angiogram
ethylene
▁8.4
imethyl
icides
▁182
▁22
tion
24
▁subcutaneous
▁averaged
▁magnesium
▁myocardial
▁92%
▁18
▁pretreated
▁(69
▁attemp
▁estimating
kets
▁(20
▁prescribed
enec
ritis
-14
odies
protein
▁adhering
▁mobilization
▁diclofenac
▁simplex
roph
▁positional
▁streptococcal
oxide
arous
▁Conventional
/30
▁0.40
▁trich
odipine
▁anemia
▁suprac
phic
▁dors
▁soluble
▁inflammatory
▁practic
▁urticaria
▁otitis
omatosis
66
▁esterase
meas
▁datab
▁SG
roscopy
.1,
▁sensi
▁64
▁1.13
▁familial
▁flashes
loride
▁300
▁antif
▁231
900
erin
▁1000
▁1986
.3.
urate
4/
xate
▁omega
ignificant
▁births
anic
ographies
emin
▁TM
97
thickness
▁4.5%
bic
18,
▁smo
illus
▁restenosis
▁triglycerides
▁187
▁77%
yocardial
▁fenoterol
tiary
▁interc
tensive
ronate
melan
▁(63
otom
-5.
▁0
▁abscesses
ospitals
▁unstable
▁(1.0
▁Functional
▁abd
▁dox
corrected
▁captopril
▁incomplete
▁(95
▁sheath
▁41
▁80%,
▁29%
-1).
▁sonography
▁-7
▁kidneys
LDL
▁-0.
-2).
▁7-
▁therapeu
vices
▁clinicians
▁secreted
▁metabolic
idate
▁socio
▁efficacy
▁econ
▁tic
▁adhesive
▁scarring
ovascular
EMG
▁neutroph
▁acetate
olysis
▁calorie
▁dosing
▁distorted
▁deleterious
urys
▁5,
▁6%,
formin
▁neutralizing
▁189
▁irrigation
iotic
▁96%
muscle
▁thrombus
▁Lyme
▁Breast
▁chan
▁descriptive
▁supplements
▁33
▁smears
▁operative
5)
▁threefold
▁1983
▁sugges
race
▁mucosa
▁avail
Ds
▁dimethyl
parous
▁intermedi
▁enrollment
▁Tiss
▁endoscopy
41
▁postmortem
▁triam
glycer
▁serum
15
irub
▁-0.8
▁Forty
▁contamin
▁(24
▁unin
orpor
▁(41%)
▁ech
▁antidepressants
▁reactive
▁randomization
▁15.8
▁ankle
▁infertility
▁doxazosin
▁esophageal
icep
ept
▁(14
▁recipients
▁cyclospor
▁kinase
▁stratif
▁neon
peptide
hyp
▁subarachnoid
▁divertic
otonic
▁algor
▁prostatectomy
▁1.0
▁1991.
▁carcin
▁plasminogen
predic
oste
▁500
▁reas
oglobulin
00
▁0.18
▁leukocytosis
▁caro
▁lipoprotein
▁cran
▁7.6
▁1986.
▁ESR
▁Doses
ophil
▁citrate
▁aspirin
▁wk
hexidine
▁176
▁550
▁PSA
▁methotrexate
▁EG
1:
▁aro
▁detrusor
▁criter
▁premature
estim
5%).
inamide
▁anxiolytic
▁carriers
▁stren
▁lesion
▁(2.6
▁2.5
distal
▁restric
ervative
▁1989
▁pelvic
▁allergens
genital
▁65
HN
osterone
▁Levels
▁76%
▁diets
▁regained
▁abduc
▁Severe
▁receptor
▁strokes
▁1)
roscopically
▁generalized
▁162
▁placent
1)
oxic
lip
▁-6
bac
uppression
▁127
▁33-
tact
nisolone
▁ison
gated
.6
amel
▁administered
ystag
▁10,
▁25%.
tin
▁polys
▁thromboembolic
orbent
rhy
tis
▁formulations
ognition
▁nausea
lamin
motor
▁proteinuria
▁1.3
▁44%
▁cohort
▁potenti
abies
▁ruptured
▁(54
▁crosso
▁phenyl
▁extrap
▁protracted
orectal
chlor
ctive
orphine
▁0.84
plasia
▁129
▁junction
▁Approximately
▁Comparing
▁hyperlipidemia
10)
▁0.21
22
yclo
▁synthesized
▁resection
▁Combined
▁decreases
▁hepatitis
▁histologic
olec
▁infancy
▁pulsed
▁comprising
▁relapses
▁1
▁stimulant
▁19,
▁anhydr
alic
terol
▁markedly
▁regimen
▁lumbosacral
▁Dip
▁albumin
▁stratified
▁93
▁1.4
azole
▁leu
▁0.01
▁cyst
▁-2
▁deli
▁11.6
lamydia
diagnosis
▁hemoglobin
aerobic
▁ocular
▁electrodes
rati
▁0.08
iatric
▁syphilis
▁3)
▁TMP
▁dextrose
▁sclerotherapy
upus
indolol
▁Patients
april
▁carvedilol
▁69
odopa
LISA
▁attainment
cessive
2;
orsal
eryth
▁308
▁promin
▁171
sants
▁pharmacokine
▁migraine
glucosidase
▁manipulation
opus
▁parat
▁capsules
▁acetaminophen
ergy
▁deposition
fatal
▁homocysteine
▁mL
▁voiding
inoc
▁myopathy
▁juvenile
▁antiarrhythmic
chol
▁incontin
▁adolescent
idne
▁BMD
▁immunosorbent
▁summarized
▁Surgical
▁gonadotroph
▁46,
▁hematoma
▁Neurop
▁scientif
2),
▁choline
▁ori
eclampsia
▁surgeon
▁measurable
3%
botic
▁attrib
▁fertility
reening
▁retardation
▁nonf
▁treadmill
▁0.19
▁unresponsive
▁paradox
▁rotavirus
positive
bladder
1.1
6-
opathy
▁Rates
▁emo
lax
▁zoster
▁7.9
▁150
▁hyperlipid
▁inconsistent
▁polycystic
▁fulminant
▁unrecognized
▁hydroly
▁0.13
▁colorectal
▁sputum
▁Maximum
▁(36%)
-1.2
▁uric
OH
▁0.44
osteroid
▁(39
▁sati
▁(9
▁rash
Hg
PV
▁enti
athered
2,000
▁discharge
▁(88%)
▁psychosis
▁hypertension
▁Extr
▁codeine
ocrine
▁biopsied
▁fecal
▁lymphocytes
▁intrav
▁labial
▁GE
▁hir
achn
Hyp
natal
58
▁0.98
plast
▁prostaglandin
▁intracranial
aminases
atients
▁nebul
▁hyperb
▁lapa
galy
▁potassium
▁Subjec
▁graft
▁clinician
ilization
▁Diabetes
▁remo
DH
▁tol
▁2.9
▁enalapril
▁contex
▁clinically
ecu
62
▁adip
▁dehydrated
▁tolerated
▁0.01).
▁pneum
▁scars
sus
pli
▁344
▁blockers
▁tet
▁0.65
▁22)
▁81%
assium
▁Subsequently
crip
▁questionnaires
▁secrete
▁prednisolone
▁neutrophil
▁13.2
▁etiologies
▁saphen
▁hydrop
formations
▁progest
▁phosph
▁epidemiological
amid
▁(2%)
▁0.05
.1%
▁wors
▁7%
▁adren
▁1991
specificity
▁8.5
▁hetero
convul
▁gonococcal
▁Interestingly
▁alcoholic
▁0.7
lactam
▁0.66
▁seroton
▁(28
▁Hb
▁tetrac
▁(6
▁(42
▁nipple
▁5000
▁empir
17
▁lar
59
weekly
▁immunoglobulin
ipril
▁cardiovascular
▁fec
▁placebo
ulants
▁hyperactivity
.7
enzyme
imodipine
yzed
▁0.82
opam
▁75-
otri
tric
▁32
glycoprotein
hep
ocortic
▁enlarge
ritten
▁evaluations
▁veins
▁headache
▁secretagog
▁PPD
0,000
apsulated
▁215
▁14%
▁acetyl
isal
▁1200
▁inducing
▁3.4
▁bony
pran
irds
9-
▁lumb
49
otrop
▁dihydro
▁reproductive
▁rupture
▁prenatal
siveness
▁rhinitis
▁symp
▁280
▁165
avage
tured
▁infec
tious
▁12.
000
▁(99
oglobin
ardized
▁rheumatic
conver
▁fung
teroidal
▁9.
▁nore
▁1.6
aldosterone
12.
obronchial
▁23
tential
▁xyl
▁293
oung
emide
▁15
▁fungus
85
tics
lood
▁specificity
▁hypertro
▁19.
▁(30
▁WHO
▁lavage
deficient
▁3.
▁40%
regulation
eliac
armac
lyb
▁substantially
menopausal
ffinities
ionine
▁adherence
6).
▁radiologic
▁88
ziness
▁hepatic
▁(12
oretically
▁methyl
▁Raynaud
▁cystic
▁CAL
▁normo
50)
▁sinusitis
▁Laser
▁ventricular
▁consul
▁Phen
5%)
loid
▁lovastatin
arying
63
▁bolus
ygen
▁ibuprofen
▁900
mum
▁66
▁abnormality
▁melanomas
▁attenu
▁fulf
estion
▁cellul
▁113
▁adolescence
▁5%.
▁chemically
▁agon
▁encompassing
sych
▁impair
▁lisinopril
rine
parathyroidism
▁Subjects
▁flexor
▁semen
▁nonspecific
▁2.3%
parative
▁100,
▁suppor
orec
▁proton
▁hypocal
▁deoxy
/12
▁(82
▁detrimental
▁hepatotoxic
▁urine
urgical
▁29
itidine
▁hypoglycemic
4-
▁1.4%
▁serolog
▁Centers
3-
▁ultim
ofl
▁recurrences
▁42,
▁30.
ereb
▁clindamycin
ilic
▁lax
dor
bumin
▁ineffective
▁300-
▁4.3
▁thrombosis
▁edema
immun
▁singlet
llate
ameth
cortisone
8).
8.
▁90%
amisole
▁differenti
▁hypothalamic
▁0.89
▁Bacter
▁dysplasia
▁relap
adrenergic
▁5.8
thmia
enal
▁elic
▁angio
▁fetal
orption
▁(100
▁alcoholics
rosis
▁(20%
POA
ronchial
▁bouts
clin
▁4.
▁osmotic
▁hospitalization
▁outbreaks
▁prognosis
▁Serum
vating
isol
▁augmentation
icillin
3]
olesterolemia
titution
▁sero
▁37
aicin
▁agglutination
▁immunization
▁dairy
▁reproducible
TSH
▁glycosyl
8%
▁123
▁defec
uates
▁drip
▁220
▁47,
ulsive
dition
estive
ller
▁intake
tensity
▁Examination
▁throm
amicin
ometers
▁vaccin
▁congen
▁44
▁epidemiologic
utions
▁Tolerance
▁poten
▁cartil
increased
econd
▁loos
▁53%
▁17,
▁inappropriate
▁neonates
▁alcoh
▁normalization
▁precur
vic
▁208
▁(=
▁palpable
▁Sodium
3),
▁57
▁injected
responders
▁albuminuria
▁(75%)
oxetine
▁Statistical
70
▁resuscitated
▁parity
Ra
amole
▁symptomatology
ectin
▁14,
46
▁abstin
-2.
seud
▁repres
1-1
▁etiology
roscopic
▁offspring
▁Lactobacillus
inol
▁CHF
ughter
▁tendons
tig
▁179
▁60
▁EE
obl
▁covariates
xual
itone
▁transfusion
ticularly
oxifen
▁pim
▁prevalences
erad
anol
▁6-
SBP
▁pell
roxen
▁ipr
▁1500
▁discus
▁antibiotic
▁kits
reduced
▁Prac
azolam
▁tetracycline
▁qualit
prising
▁diffus
plenic
▁mononucle
▁venti
▁anomalies
amide
▁fatty
▁inver
tiz
▁minimally
▁DVT
▁(1/
oconazole
▁endoscopically
▁equivocal
deficiency
▁insufficiency
haled
glycerin
▁ultrasound
▁peri
▁carcinoma
▁unipolar
tine
▁7.7
▁assessing
valvular
▁rehabilitation
▁nec
4,
▁1.7
▁immunocompetent
lusion
▁allergen
▁1600
▁clom
▁stent
vertebral
▁1.5-
creatinine
▁7.1
osal
99
▁developmental
9,
▁adi
▁infar
▁(48
9).
tissue
FEV
44,
▁rebound
▁decreas
▁identically
▁mite
▁exer
▁205
▁conductance
▁multin
▁Hep
▁11-
▁specifying
▁(0.4
▁Successful
▁excretion
▁niacin
▁luteal
opharynx
▁electromy
▁15-
▁thyroxine
▁5.0
▁ipratropium
▁zinc
▁posttreatment
▁GAD
coun
fate
▁Mild
▁criterion
DNA
▁Invent
▁exhaustion
▁atyp
▁muc
adequ
▁(43
arbonate
ofil
▁eradicated
▁psoriasis
ocyst
▁reser
▁benzo
▁reti
▁60%
▁diminished
▁felodipine
HF
▁0.97
▁mmol
▁0.86
▁enzymes
▁unusually
▁Milk
▁200,
▁coated
▁obser
▁MCV
fraction
uria
▁glucosamine
▁IgM
erebral
▁0.49
▁SIDS
7-
▁(1.4
1%
▁pregnancies
▁antimicrobial
resist
▁instrum
▁immunity
gag
▁obstetric
olol
▁diagnos
▁170
tiv
rometry
centr
▁9-
continu
ocytes
strual
elec
oxygen
nee
limb
▁1.16
operatively
▁0.28
-70
▁ingu
idazole
▁bip
itonin
propanol
ervical
▁retinopathy
reased
▁presumed
▁268
▁pyr
odular
amethasone
anate
▁0.61
▁hemat
▁(75
▁96
▁accessibility
ingers
tosis
▁bowel
▁menstr
oplasia
▁ascer
▁meningitis
▁venous
uncture
▁luteinizing
▁nig
inum
▁(400
tituted
▁tas
▁4
▁Apgar
NB
▁underwent
▁osm
6;
▁nicotine
▁Factors
▁fracture
Ly
oreal
▁androgen
▁carbonate
▁factorial
pirin
▁confir
▁diazepam
▁CVD
▁devi
▁induction
conduc
▁0.27
▁hypox
tomy
▁(68%)
▁dorsal
▁contraction
asal
▁inhaled
▁brom
5%.
▁subfractions
▁extracts
▁casein
▁tach
80
7%)
▁(32%)
opre
▁hypers
jective
1-2
▁fatigue
▁reversed
▁0.25%
crib
▁psor
▁dizziness
▁63%
titutes
usate
▁keto
ocated
adder
osac
opathic
okine
esity
▁IgG
28
angl
▁Systolic
ogenicity
odium
▁concom
▁1.2%
▁0.48
▁carbohyd
▁48%
▁109
▁irregular
esin
▁0.52
▁calcitonin
absorption
▁morbidity
.3%
queous
isole
▁cuff
▁dermatitis
▁0.22
▁electrolytes
▁eti
▁36%
calor
▁qualitatively
elves
gesia
▁amn
oprost
▁propor
-400
:3
▁hypocalcemia
▁Dys
▁psychotherapy
▁1985
▁limbs
▁hypercalcemia
-3
▁COPD
sian
▁quinine
▁chl
▁stratification
▁700
olone
▁phosphate
▁communic
▁27,
quisition
tenti
entral
jec
▁2000
rates
▁hazards
39
▁(63%)
▁contraceptives
▁100%.
resis
vedilol
ylic
▁tricyclic
▁2.1
▁0.02
▁30%
.6%
struc
▁acad
plasty
▁anxio
urnal
▁systolic
▁5)
iphene
▁saturation
▁computerized
▁16
trial
▁164
veness
amphenicol
▁2.4%
▁terfenadine
venous
▁elevations
eded
albumin
iloride
▁LD
▁ae
▁injections
uris
▁psychophysical
eal
▁idiopathic
▁wheezing
spectively
▁Few
▁13.9
▁Identif
▁infrequent
leb
▁cardio
▁tiss
▁prophyl
▁adrenal
▁ket
▁prognostic
edding
▁pleural
ecre
▁demonstrating
gative
▁endogenous
▁steroids
sulf
ulence
onvul
▁amlodipine
hea
▁nitrogen
thromb
▁Ultras
▁solids
▁Disease
BV
sant
▁hyperbil
▁rheumatoid
▁hysterectomy
erant
tisol
emia
rogenic
▁cortic
astatic
otassium
▁unrel
▁oxytocin
atible
▁2.
ustained
▁absorp
▁Ace
apanese
▁iat
ocomp
▁40,000
▁3.5%
▁ambulatory
▁(89
▁newborns
▁gastro
▁30%.
ifedipine
▁1990
▁clamping
▁immunogenicity
▁mann
▁thirds
hydroxyp
omerular
onad
ffer
TG
availability
atology
▁clon
600
▁agonists
▁oxym
▁exhibited
▁tremor
▁individualized
25
▁disadvantage
▁experim
▁nitroglycerin
▁antenatal
-1
▁102
tral
▁rehabil
▁arti
▁295
▁0.4%
▁duplex
▁prevalence
▁glycoprotein
▁deviations
▁rigor
▁definitive
▁fractions
iatic
▁4.1
▁MM
▁retur
▁bronchodil
▁scl
tene
till
▁premenopausal
initiated
▁Veterans
▁35-
▁FD
▁24,
▁disseminated
leukin
▁Concentrations
▁metast
▁unsuitable
quid
assessed
reness
▁tuberculosis
obac
▁uter
▁protoc
ucas
ytoin
lob
-50%
▁affinities
▁excluding
▁Ear
adin
rography
▁8%,
partum
▁restraint
▁lesions
▁stimulation
Ni
isters
▁rats
timate
▁lipid
vitamin
dens
athyroid
idone
▁weighed
5).
hetamine
dent
tionally
▁0.
sess
▁neuropsych
▁compounds
cys
▁Recurrent
▁unres
▁candidiasis
▁margins
▁methionine
-10
ensi
▁exposures
enol
▁lumbar
tension
▁17.
▁warts
13
▁(19
▁disturbance
▁undergoing
▁eczema
▁spi
romised
▁0.70
▁arousal
▁DSM
▁choles
▁0.63
phen
▁98%
▁discom
▁85
MH
▁hemo
▁0.09
▁enteral
cycline
▁augmenting
eptin
▁endocrine
▁TP
▁adap
▁artifact
▁ow
asone
restricted
ypass
▁amput
individual
▁exacerbations
▁3.9
▁halves
anide
▁2,
thoracic
▁150-
▁14.
▁cumulative
▁145
6)
illin
tox
▁Treatment
▁0.04
▁Neu
18
▁0.77
elic
▁proportions
▁10-
aryngeal
.1
▁amplification
▁immunobl
posure
▁matur
athic
▁staging
aminop
astolic
▁infrequently
▁topically
cemia
carbohydrate
zation
▁32%
▁0%,
▁Ventricular
▁successive
▁vertebral
▁hyperplasia
orbidity
▁69%
▁titr
▁leukotriene
▁11,
▁177
▁ane
ostic
▁eradic
▁nonex
tronic
2%)
14
▁elas
containing
▁resistant
▁influenzae
▁diffic
▁nonsmokers
▁159
▁mortality
▁38%
▁217
▁Registry
▁schiz
LTS
▁pediatric
▁parac
▁0.9
▁polyethylene
▁physicians
▁fluoro
26
vail
▁4)
▁2.1%
▁50,
▁0.06
acycl
▁correlate
charged
▁12-
▁retention
▁243
▁-0.0
▁Seventeen
▁unchanged
▁iso
▁embry
economic
▁anoxic
▁-4
▁introduc
.9%
▁perioperative
▁coronary
▁MRI
▁coping
▁exhaus
▁investigator
▁polymyxin
▁transi
▁cystitis
▁numb
molecular
▁252
▁aspartate
▁68%
luc
▁medically
▁thromboembolism
acid
▁competent
▁variability
idney
versity
▁diaz
▁assay
▁cartilage
▁correlated
▁amphetamine
▁26%
▁(1
▁endemic
rologic
promoting
inemia
▁tubes
▁10%.
trated
0-
opres
▁predictive
0/
radi
▁Infection
▁diuretic
▁metabolism
▁3.6%
▁29,
▁prolonged
amphetamine
-1.1
▁oils
▁8-
ocardi
▁Nutrition
BMI
dominal
▁tonsillar
▁desatur
▁(80
▁0.71
promazine
▁(31%)
▁Addition
pore
hips
▁whey
mental
vice
▁lep
determined
▁overt
▁positives
potential
▁1.11
5%),
▁dissection
▁palp
oten
▁caries
ressive
▁donors
18)
▁oste
TCA
moderate
▁34%
▁melan
79
▁bronchial
sectional
▁deliveries
▁anticonvulsant
strain
udation
▁cessation
▁varicella
▁endometri
▁somatic
▁fluc
admill
anad
▁antibodies
floxacin
▁atherosclerotic
ystic
▁lowering
▁lorazepam
▁thir
▁40.
▁Caucas
aturia
▁Seventy
▁sodium
▁ceftriaxone
caro
trogen
ranial
▁0.8%
ociation
▁35
▁Clinical
▁gases
Cu
daily
ronch
echanical
▁granuloma
fetoprotein
▁iden
▁136
▁multic
pecific
▁10.4
pig
urther
injection
▁differing
.5.
aryn
uterine
▁asymptomatic
▁cosmetic
▁4;
▁inspiratory
▁sampled
▁rigorous
▁confound
ochem
▁bacteri
▁progres
mia
▁dor
▁unpredictable
▁199
▁satis
▁(22
▁ester
0.1
acchar
arrhythmic
▁UT
▁79
▁transluminal
ordial
▁0.7,
▁statis
idic
▁intestinal
▁incompetence
vation
▁80
▁fric
4%
▁168
▁inadequate
71
scherichia
▁postin
▁6.1
hormonal
▁serogroup
ogens
▁bronch
leural
78
initi
cents
yclic
▁Surgery
▁verte
▁thrombotic
ubs
dihyd
▁stool
cyte
▁fractures
▁viral
▁bloc
▁Fifteen
▁neutrop
thyl
pressing
▁Comparison
▁confirming
▁Cardiovascular
romy
▁72
▁viruses
▁acne
▁0.00
▁electr
▁incis
▁hepatocellular
astatin
algia
cture
▁paternal
▁implants
psych
▁interfer
▁clus
▁aneurysms
orated
oxine
edocromil
▁respec
▁83%
▁2-
▁Absolute
rance
▁gonad
otroph
30)
onography
▁2
▁latex
▁62%
tition
75
▁Engl
diagn
▁metastatic
▁0.47
▁indomethacin
▁lipophilic
▁strains
agic
nish
ectable
▁enal
▁53
▁propranolol
▁serotonergic
92
▁conception
60)
HDL
▁0.43
▁endoscopic
▁hairs
▁Holter
▁7,
▁fas
▁enlarged
▁160
▁serologically
▁(1)
luding
▁calor
▁rati
▁nif
▁0.9%
47
farin
▁92
urine
0.6
110
